Submitted by Anonymous (not verified) on 24 March 2026 - 15:08
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 7, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Grasustek, pegfilgrastim, Date of authorisation: 20/06/2019, Revision: 7, Status: Authorised